Crinetics Pharmaceuticals

Yahoo Finance • 2 days ago

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purc... Full story

Yahoo Finance • 6 days ago

Crinetics Pharmaceuticals Inc Q3 Loss Increases, Misses Estimates

(RTTNews) - Crinetics Pharmaceuticals Inc (CRNX) reported Loss for its third quarter that increased from the same period last year and missed the Street estimates. The company's earnings came in at -$130.09 million, or -$1.38 per share.... Full story

Yahoo Finance • last month

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purch... Full story

Yahoo Finance • last month

Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market closes. Company managemen... Full story

Yahoo Finance • 2 months ago

Stocks Finish Higher as Core PCE Prices Match Expectations

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Friday closed up +0.59%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/f... Full story

Yahoo Finance • 2 months ago

Notable Friday Option Activity: TDOC, CRNX, WYNN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (Symbol: TDOC), where a total of 35,521 contracts have traded so far, representing approximately 3.6 million un... Full story

Yahoo Finance • 2 months ago

Stocks Climb on Strength in Consumer Spending and Tame Inflation

The S&P 500 Index ($SPX) (SPY) today is up +0.56%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.81%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.28%.  December E-mini S&P futures (ESZ25) are up +0.53%, and December E-mini Nas... Full story

Yahoo Finance • 2 months ago

Stocks Turn Mixed as US Consumer Sentiment Slips

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.10%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story

Yahoo Finance • 2 months ago

Crinetics wins FDA approval for acromegaly therapy

[US Food and Drug Administration (FDA)] Crinetics Pharmaceuticals (NASDAQ:CRNX [https://seekingalpha.com/symbol/CRNX]) has received approval for its lead asset, Palsonify (paltusotine), as a first-line treatment for adults with acromegaly... Full story

Yahoo Finance • 2 months ago

Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerate... Full story

Yahoo Finance • 2 months ago

Interesting CRNX Put And Call Options For November 21st

Investors in Crinetics Pharmaceuticals Inc (Symbol: CRNX) saw new options begin trading this week, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRNX options chain for the n... Full story

Yahoo Finance • 2 months ago

Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to pu... Full story

Yahoo Finance • 3 months ago

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel, once-daily oral a... Full story

Yahoo Finance • 3 months ago

Tuesday's pre-market session: top gainers and losers

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT LASE [https://www.chartm... Full story

Yahoo Finance • 3 months ago

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purcha... Full story

Yahoo Finance • 3 months ago

Crinetics stock price target lowered to $86 by Citizens JMP on launch outlook

Investing.com - Citizens JMP has lowered its price target on Crinetics (NASDAQ:CRNX) to $86.00 from $90.00 while maintaining a Market Outperform rating, citing expectations for a modest initial launch of the company’s acromegaly treatment.... Full story

Yahoo Finance • 3 months ago

Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a... Full story

Yahoo Finance • 3 months ago

Crinetics Pharmaceuticals GAAP EPS of -$1.23 misses by $0.13, revenue of $1M beats by $0.51M

* Crinetics Pharmaceuticals press release [https://seekingalpha.com/pr/20194062-crinetics-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides-business] (NASDAQ:CRNX [https://seekingalpha.com/symbol/CRNX]): Q2 GAAP... Full story

Yahoo Finance • 4 months ago

Crinetics' 48% decline validates InvestingPro's October 2024 overvalued call

In October 2024, Investing.com’s Fair Value model identified Crinetics Pharmaceuticals (NASDAQ:CRNX) as significantly overvalued, demonstrating the power of sophisticated valuation analysis in protecting investor capital. The subsequent ma... Full story

Yahoo Finance • 4 months ago

H.C. Wainwright reiterates Buy rating on Crinetics stock at $81 price target

Investing.com - H.C. Wainwright has reiterated its Buy rating and $81.00 price target on Crinetics (NASDAQ:CRNX) following the ENDO 2025 conference. The target represents significant upside from the current price of $31.11, with analyst ta... Full story